Insider Transactions in Q2 2023 at Esperion Therapeutics, Inc. (ESPR)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 21
2023
|
Eric Warren Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
603
-0.86%
|
$603
$1.48 P/Share
|
|
Jun 15
2023
|
Alan Fuhrman Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,150
+14.49%
|
-
|
|
Jun 15
2023
|
Antonio M Jr Md D Phil Gotto Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,150
+15.26%
|
-
|
|
Jun 15
2023
|
Stephen Rocamboli Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,150
+27.97%
|
-
|
|
Jun 15
2023
|
Jay Shepard Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,150
+15.26%
|
-
|
|
Jun 15
2023
|
Nicole Vitullo Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,150
+12.24%
|
-
|
|
Jun 15
2023
|
J Martin Carroll Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,150
+11.0%
|
-
|
|
Jun 15
2023
|
Seth H. Z. Fischer Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,150
+50.0%
|
-
|
|
Jun 15
2023
|
Tracy M Woody Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,150
+13.3%
|
-
|
|
May 17
2023
|
Eric Warren Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
219
-0.31%
|
$219
$1.62 P/Share
|
|
May 11
2023
|
J Martin Carroll Director |
BUY
Open market or private purchase
|
Direct |
23,091
+38.75%
|
$23,091
$1.57 P/Share
|
|
May 10
2023
|
Stephen Rocamboli Director |
BUY
Open market or private purchase
|
Direct |
8,111
+50.0%
|
$8,111
$1.5 P/Share
|
|
May 10
2023
|
J Martin Carroll Director |
BUY
Open market or private purchase
|
Direct |
8,409
+38.54%
|
$8,409
$1.49 P/Share
|
|
May 09
2023
|
Sheldon L. Koenig President and CEO |
BUY
Open market or private purchase
|
Direct |
20,000
+6.01%
|
$20,000
$1.26 P/Share
|
|
Apr 19
2023
|
Joanne M. Foody Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
938
-0.73%
|
$938
$1.27 P/Share
|
|
Apr 19
2023
|
Benjamin Looker General Counsel |
SELL
Open market or private sale
|
Direct |
1,290
-1.52%
|
$1,290
$1.27 P/Share
|
|
Apr 19
2023
|
Eric Warren Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
115
-0.16%
|
$115
$1.28 P/Share
|